Clinical trial
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
NCT00445575 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 22, 2007
- Completion date
- December 7, 2017
- Enrollment
- 80 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.